March 15 (Reuters) - Nektar Therapeutics ( NKTR ):
* TCG CROSSOVER GP II, LLC FILES TO REPORT PASSIVE STAKE OF
9.99%
IN NEKTAR THERAPEUTICS AS OF MARCH 6, 2024 - SEC FILING
Source text for Eikon:
Further company coverage: